Clinical Trial Update: Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

This phase 1 trial evaluated the combination of lenalidomide and dacarbazine in patients with metastatic melanoma and is now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Revlimid (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1 | Status: COMPLETED